The data storage company has secured backing from Legend Holdings and Hundsun to further develop its technology.
Month: September 2021
Baidu Ventures bags $400m for Fund III
Baidu is a limited partner in the third fund of its AI-focused investment unit, Baidu Ventures.
Allsaints Music Group streams $60m series B1
Oppo and Xiaomi have backed the streaming service leveraging blockchain for user content.
Olio obtains $43m in series B
Food-sharing platform Olio is eyeing foreign markets with series B funding raised from investors including Delivery Hero’s corporate venture capital unit.
Homage honoured by $30m series C
Senior care provider Homage has added series C financing to its coffers.
Agricorp International plants series A funding
Ginger supplier Agricorp International has attracted $17.5m of series A funding from backers including AFEX and Vami Farms.
Analysis: Databricks lays out $1.6bn
The data analytics software producer, which counts Alphabet, Salesforce and Amazon among as backers, raised a $1.6bn series H at $38bn valuation. It is a case in point for the upward pressure in valuations of companies from this space which we have been seeing.
HomeLight lists $363m deal
The Citi and Alphabet-backed real estate platform hauled in $100m in series D equity and $263m in debt.
Daily Deal Round Up: September 3, 2021
Versanis Bio secured $70 to commercialise a treatment licensed from Novartis, while Salesforce, Intel, Orange, Nike and Alphabet all celebrated exits.
Checkr screens $250m series B
The GV-backed candidate checking platform developer is fuelling its growth with fresh capital from FMR and stalwart investor T Rowe Price.
Cosmoplat coordinates $155m series B
China Life has boosted the industrial internet-of-things specialist in its quest to deliver the advantages of industry 4.0.
Cue Health chooses Nasdaq Global Market for IPO
Johnson & Johnson Innovation – JJDC, Koch Strategic Platforms and Dentsu Ventures are all shareholders in the diagnostic testing technology developer.
Disc Medicine injects $90m in series B
The blood disease specialist secured a boost from Alexandria Real Estate Equities, Novo and Access Biotechnology to move two assets into phase 2 trials.
Corelight concentrates $75m into series D
The cybersecurity platform operator has achieved $160m of total funding through a series D round backed by Capital One and CrowdStrike.